Meredith A Gunder, Tonner DeBeer, Julie A Siegel, Michael E Egger, Kelly M McMasters, Robert C G Martin, Prejesh A Philips, Gary C Vitale, Charles R Scoggins
{"title":"转移模式对胰腺癌切除术后生存的影响。","authors":"Meredith A Gunder, Tonner DeBeer, Julie A Siegel, Michael E Egger, Kelly M McMasters, Robert C G Martin, Prejesh A Philips, Gary C Vitale, Charles R Scoggins","doi":"10.1002/jso.28058","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and methods: </strong>The incidence of pancreatic cancer is increasing, and up to 55% of patients present with metastatic disease at the time of diagnosis. Many patients also develop metastatic disease following surgical resection. The impact of metastatic patterns on outcomes has not been described. A retrospective chart review was conducted of patients with pancreatic adenocarcinoma treated at a tertiary care center from 2012 to 2023. Patients who presented with metastatic disease or developed metastatic disease during their treatment course were identified. Univariate analysis was performed to identify factors associated with specific metastatic patterns. Kaplan-Meier survival curves were estimated for metastatic sites and stratified by treatment.</p><p><strong>Results: </strong>Of the 330 patients identified, 192 (58.2%) presented with locoregional disease and underwent curative intent surgery before developing metastases, and 138 (41.8%) presented initially with metastatic disease. Median overall survival (OS) with metastases for all patients was 6 months. For patients who underwent curative intent surgery, OS was significantly worse for those who developed peritoneal metastasis compared to patients who developed other sites of metastases (median OS 5.4 vs. 9.2 months, p = 0.0005).</p><p><strong>Conclusion: </strong>The development of peritoneal metastases after surgery for pancreatic cancer is associated with worse OS compared to other sites of metastatic disease.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of Metastatic Pattern on Survival Following Pancreatectomy for Cancer.\",\"authors\":\"Meredith A Gunder, Tonner DeBeer, Julie A Siegel, Michael E Egger, Kelly M McMasters, Robert C G Martin, Prejesh A Philips, Gary C Vitale, Charles R Scoggins\",\"doi\":\"10.1002/jso.28058\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and methods: </strong>The incidence of pancreatic cancer is increasing, and up to 55% of patients present with metastatic disease at the time of diagnosis. Many patients also develop metastatic disease following surgical resection. The impact of metastatic patterns on outcomes has not been described. A retrospective chart review was conducted of patients with pancreatic adenocarcinoma treated at a tertiary care center from 2012 to 2023. Patients who presented with metastatic disease or developed metastatic disease during their treatment course were identified. Univariate analysis was performed to identify factors associated with specific metastatic patterns. Kaplan-Meier survival curves were estimated for metastatic sites and stratified by treatment.</p><p><strong>Results: </strong>Of the 330 patients identified, 192 (58.2%) presented with locoregional disease and underwent curative intent surgery before developing metastases, and 138 (41.8%) presented initially with metastatic disease. Median overall survival (OS) with metastases for all patients was 6 months. For patients who underwent curative intent surgery, OS was significantly worse for those who developed peritoneal metastasis compared to patients who developed other sites of metastases (median OS 5.4 vs. 9.2 months, p = 0.0005).</p><p><strong>Conclusion: </strong>The development of peritoneal metastases after surgery for pancreatic cancer is associated with worse OS compared to other sites of metastatic disease.</p>\",\"PeriodicalId\":17111,\"journal\":{\"name\":\"Journal of Surgical Oncology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-12-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Surgical Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/jso.28058\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jso.28058","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景和方法:胰腺癌的发病率正在增加,高达55%的患者在诊断时存在转移性疾病。许多患者在手术切除后也会发生转移性疾病。转移模式对预后的影响尚未被描述。对2012年至2023年在三级保健中心治疗的胰腺腺癌患者进行回顾性图表回顾。在治疗过程中出现转移性疾病或发展为转移性疾病的患者被确定。进行单因素分析以确定与特定转移模式相关的因素。Kaplan-Meier生存曲线估计转移部位,并按治疗分层。结果:在确定的330例患者中,192例(58.2%)表现为局部疾病,并在发生转移前接受了治疗目的手术,138例(41.8%)最初表现为转移性疾病。所有转移患者的中位总生存期(OS)为6个月。对于接受治疗目的手术的患者,发生腹膜转移的患者的OS明显差于发生其他部位转移的患者(中位OS 5.4 vs. 9.2个月,p = 0.0005)。结论:与其他部位的转移性疾病相比,胰腺癌术后腹膜转移的发生与更差的OS相关。
Impact of Metastatic Pattern on Survival Following Pancreatectomy for Cancer.
Background and methods: The incidence of pancreatic cancer is increasing, and up to 55% of patients present with metastatic disease at the time of diagnosis. Many patients also develop metastatic disease following surgical resection. The impact of metastatic patterns on outcomes has not been described. A retrospective chart review was conducted of patients with pancreatic adenocarcinoma treated at a tertiary care center from 2012 to 2023. Patients who presented with metastatic disease or developed metastatic disease during their treatment course were identified. Univariate analysis was performed to identify factors associated with specific metastatic patterns. Kaplan-Meier survival curves were estimated for metastatic sites and stratified by treatment.
Results: Of the 330 patients identified, 192 (58.2%) presented with locoregional disease and underwent curative intent surgery before developing metastases, and 138 (41.8%) presented initially with metastatic disease. Median overall survival (OS) with metastases for all patients was 6 months. For patients who underwent curative intent surgery, OS was significantly worse for those who developed peritoneal metastasis compared to patients who developed other sites of metastases (median OS 5.4 vs. 9.2 months, p = 0.0005).
Conclusion: The development of peritoneal metastases after surgery for pancreatic cancer is associated with worse OS compared to other sites of metastatic disease.
期刊介绍:
The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.